CJC-1295 DAC 5mg

For Research Purposes Only. Not intended for human consumption.

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) featuring a lysine-based Drug Affinity Complex that extends its half-life by enabling reversible binding to serum albumin. This modification produces prolonged growth hormone secretagogue activity compared to unmodified GHRH analogs.

Research Overview

CJC-1295 DAC research has examined its pharmacokinetic profile, dose-dependent growth hormone and IGF-1 secretion patterns, and sustained pulsatile release characteristics. It is among the most extensively researched GHRH analogs in the scientific literature.

Key Research Areas

• Growth hormone secretagogue mechanisms and pharmacokinetics
• IGF-1 axis modulation research
• Body composition and lean tissue research models
• Albumin binding and extended half-life studies
• Metabolic rate and fat oxidation research

Product Specifications

• Form: Lyophilized powder
• Purity: ≥98% (HPLC verified)
• Quantity: 5mg per vial
• Testing: Independent third-party COA available
• Storage: Store at -20°C. Stable at 4°C short-term.
• CAS Number: 863288-34-0

For laboratory research purposes only. Not approved for human or veterinary use.

The information provided here is for educational and research purposes only. All studies referenced are preclinical or in vitro unless otherwise noted. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any condition.

Researchers should review all available literature and consult appropriate regulatory guidelines before use. Certificate of Analysis documents for each lot are available in our COA Library.